Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Value of Intratumoral Expression of Claudin 18.2 in Resected Pancreatic Cancer.

Annals of surgical oncology·2026
Same author

Prevalence and Clinical Characteristics of Chronic Venous Insufficiency among Individuals with Lower Extremity Lymphoedema: A Systematic Review and Meta-analysis.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2026
Same author

Genomic Medicine Sweden: Advancing precision medicine at the national level.

Journal of internal medicine·2026
Same author

Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertainties.

Journal of neuro-oncology·2026
Same author

Optimizing reporting and outreach for surveillance and risk-reducing surgeries for cancer genetic predisposition: Findings of a workshop organized by the International Cascade Consortium.

Public health genomics·2026
Same author

Pituitary Metastasis in Lung Cancer Patients: Case Series and Review of the Literature.

Current oncology (Toronto, Ont.)·2026

Related Experiment Video

Updated: Apr 4, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.4K

Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 Carriers.

Rebecca Wiberg1, Signe Hägglund1, Barbro Numan Hellquist2

  • 1Department of Diagnostics and Intervention, Plastic Surgery and Surgery, Umeå University, Umeå, Sweden.

JAMA Network Open
|April 3, 2026
PubMed
Summary

Risk-reducing mastectomy (RRM) significantly lowers breast cancer risk in BRCA1/2 carriers, with very low rates of cancer and surgical complications. This study confirms RRM safety and effectiveness for high-risk women.

More Related Videos

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

4.9K
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

14.1K

Related Experiment Videos

Last Updated: Apr 4, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.4K
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

4.9K
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

14.1K

Area of Science:

  • Oncology
  • Genetics
  • Surgical Oncology

Background:

  • Long-term safety data on risk-reducing mastectomy (RRM) for women with BRCA1/2 germline pathogenic variants (gPVs) are limited.
  • Understanding cancer risk and surgical complication rates post-RRM is crucial for informed decision-making in high-risk populations.

Purpose of the Study:

  • To evaluate the long-term cancer risk following RRM in women with BRCA1/2 gPVs.
  • To assess the incidence of surgical complications after RRM in this cohort.
  • To compare cancer risk between women who underwent RRM and those who did not.

Main Methods:

  • A nationwide cohort study of 1208 Swedish women with BRCA1/2 gPVs without prior breast cancer.
  • Data linkage with national registers (Patient Care, Cancer, Cause of Death) for comprehensive follow-up.
  • Comparison of breast cancer incidence and surgical complication rates between RRM and no-RRM groups.

Main Results:

  • Women undergoing RRM had a significantly lower breast cancer incidence (2 per 10,000 person-years) compared to the no-RRM group (162 per 10,000 person-years).
  • Occult breast cancer was diagnosed in 3.4% of women at the time of RRM.
  • Early major surgical complications requiring reoperation occurred in 3.7% of women post-RRM, with implant-based reconstruction being most common.

Conclusions:

  • RRM is associated with a very low risk of developing breast cancer in women with BRCA1/2 gPVs.
  • The rate of early major surgical complications following RRM is low.
  • The study supports the safety and efficacy of RRM in reducing breast cancer risk for high-risk individuals.